Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Some, Surajit ^a   Gwon, A Ryeong ^a   Hwang, Eunhee ^a   Bahn, Ga Hee ^a   Yoon, Yeoheung ^a   Kim, Youngmin ^a   Kim, Seol Hee ^a   Bak, Sora ^a   Yang, Junghee ^a   Jo, Dong Gyu ^a   Lee, Hyoyoung ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; DRUG CARRIER; GRAPHITE; NANOCOMPOSITE; QUANTUM DOT;

ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; FEMALE; HCT116 CELL LINE; HUMAN; MOUSE; NEOPLASMS; SCANNING ELECTROCHEMICAL MICROSCOPY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DRUG CARRIERS; FEMALE; GRAPHITE; HCT116 CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTROCHEMICAL, SCANNING; NANOCOMPOSITES; NEOPLASM TRANSPLANTATION; NEOPLASMS; QUANTUM DOTS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84919771408     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06314     Document Type: Article

References (34)

1. Liu, Z., Sun, X., Nakayama-Ratchford, N. & Dai, H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 1, 50-56 (2007).
2. Peng, F. et al. Silicon-nanowire-based nanocarriers with ultrahigh drug-loading capacity for in vitro and in vivo cancer therapy. Angew. Chem. Int. Ed. 52, 1457-1461 (2013).
3. Liu, Z., Robinson, J. T., Sun, X. M. & Dai, H. J. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J. Am. Chem. Soc. 130, 10876-10877 (2008).
4. Nurunnabi, M. et al. In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano 7, 6858-6867 (2013).
5. Nahain, A. et al. Target delivery and cell imaging using hyaluronic acid-functionalized graphene quantum dots. Mol. Pharmaceutics 10, 3736-3744 (2013).
6. Hu, C.-M. J. & Zhang, L. Therapeutic nanoparticles to combat cancer drug resistance. Curr. Drug Metab. 10, 836-841 (2009).
7. Jabr-Milane, L. S., van Vlerken, L. E., Yadav, S. & Amiji, M. M. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat. Rev. 34, 592-602 (2008).
8. Shen, H., Zhang, L., Liu, M. & Zhang, Z. Biomedical applications of graphene. Theranostics 2, 283-294 (2012).
9. Zhang, L. M. et al. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6, 537-544 (2010).
10. Sahoo, N. G. et al. Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Chem. Commun. 47, 5235-5237 (2011).
11. Feng, L. Z. & Liu, Z. A. Graphene in biomedicine: opportunities and challenges. Nanomedicine 6, 317-324 (2011).
12. Bao, H., Pan, Y. & Li, L. Recent advances in graphene-based nanomaterials for biomedical applications. Nano Life 02, 1230001-1230015 (2012).
13. Liu, C. et al. Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model. Biomacromolecules 14, 358-366 (2013).
14. Arayachukeat, S., Palaga, T. & Wanichwecharungruang, S. P. Clusters of carbon nanospheres derived from graphene oxide. ACS Appl. Mater. Interfaces 4, 6808-6815 (2012).
15. Wang, Z. et al. Synthesis of strongly green-photoluminescent graphene quantum dots for drug carrier. Colloids Surf. B-Biointerfaces 112, 192-196 (2013).
16. Wang, C. et al. Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots. Sci Rep. 3, 2852-2860 (2013).
17. Sanchez, V. C., Jachak, A., Hurt, R. H. & Kane, A. B. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem. Res. Toxicol. 25, 15-34 (2011).
18. Lee, D. Y., Khatun, Z., Lee, J. H., Lee, Y. K. & In, I. Blood compatible graphene/heparin conjugate through noncovalent chemistry. Biomacromolecules 12, 336-341 (2011).
19. Grigoryan, G. et al. Computational design of virus-like protein assemblies on carbon nanotube surfaces. Science 332, 1071-1076 (2011).
20. Yang, K., Feng, L., Shi, X. & Liu, Z. Nano-graphene in biomedicine: theranostic applications. Chem. Soc. Rev. 42, 530-547 (2013).
21. Yang, K., Li, Y., Tan, X., Peng, R. & Liu, Z. Behavior and toxicity of graphene and its functionalized derivatives in biological systems. Small 9, 1492-1503 (2013).
22. Wu, J. et al. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells. Nanotechnology 23, 355101-355110 (2012).
23. Some, S. et al. Can commonly used hydrazine produce n-type graphene? Chem. A Eur. J. 18, 7665-7670 (2012).
24. Hong, B. J., Compton, O. C., An, Z., Eryazici, I. & Nguyen, S. T. Successful stabilization of graphene oxide in electrolyte solutions: enhancement of biofunctionalization and cellular uptake. ACS Nano 1, 63-73 (2012).
25. Some, S. et al. Dual functions of highly potent graphene derivative-poly-L-lysine composites to inhibit bacteria and support human cells. ACS Nano 8, 7151-7161 (2012).
26. Mohan, P.R.K., Sreelakshmi, G., Muraleedharan, C.V. & Joseph, R.Water soluble complexes of curcumin with cyclodextrins: characterization by FT-raman spectroscopy. Vib. Spectrosc. 62, 77-84 (2012).
27. Leung, M. H. M., Colangelo, H. & Kee, T. W. Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. Langmuir 24, 5672-5675 (2008).
28. Peng, J. et al. Graphene quantum dots derived from carbon fibers. Nano lett. 12, 844-849 (2012).
29. Mathew, A. et al. Curcumin loaded-PLGA nanoparticles conjugated with tet-1 peptide for potential use in alzheimer's disease. PLoS ONE 7, 32616-32626 (2012).
30. Zhu, S. et al. Graphene quantum dots with controllable surface oxidation, tunable fluorescence and up-conversion emission. RSC Advances 2, 2717-2720 (2012).
31. Patra, D. & Sleem, F.Anew method forpH triggered curcumin releasebyapplying poly(l-lysine) mediated nanoparticle-congregation. Anal. Chim. Acta 795, 60-68 (2013).
32. Wang, P., Yu, J. & Zhang, L. The nuclear function of p53 is required for PUMAmediated apoptosis induced by DNA damage. Proc. Natl. Acad. Sci. U. S. A. 2007 104, 4054-4059 (2007).
33. Mobasher, M. A. et al. Protein tyrosine phosphatase 1B modulates GSK3b/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity. Cell Death & Disease 4, 626-639 (2013).
34. 3 nanorods. Biomaterials 34, 508-515 (2013).